Market Cap 65.30M
Revenue (ttm) 0.00
Net Income (ttm) -22.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.46
Volume 259,300
Avg Vol 548,840
Day's Range N/A - N/A
Shares Out 12.25M
Stochastic %K 77%
Beta -0.81
Analysts Strong Sell
Price Target $26.40

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
StockJock73
StockJock73 May. 8 at 10:18 PM
$CING Just wake me up on May 32nd with an FDA approval please !!! šŸ€šŸ€šŸ€šŸ‚šŸ‚šŸ‚
0 Ā· Reply
alfi79
alfi79 May. 8 at 9:24 PM
$CING big buys today guys from VanguardšŸ˜±šŸ’Ŗ smart money is already starting to position itself!!!
1 Ā· Reply
PaulWalter
PaulWalter May. 8 at 8:25 PM
$CING Well, they haven’t buried bad news late on a Friday. Very cautiously optimistic.
0 Ā· Reply
Merlintrader
Merlintrader May. 8 at 7:50 PM
$CING Cingulate ( $CING ) vs Aytu BioPharma ( $AYTU ): What a Commercial ADHD Peer Can — and Cannot — Tell Us Before CING’s May 31 PDUFA https://www.merlintrader.com/cingulate-vs-aytu-biopharma-may2026-comparison/
0 Ā· Reply
biotechMDshortcut
biotechMDshortcut May. 8 at 3:58 PM
$CING full steam ahead. 24k in this boy for pdufa. 20% stop loss.
1 Ā· Reply
hossam94
hossam94 May. 8 at 2:02 PM
$CING someone know anything herešŸ˜‘?!
1 Ā· Reply
Laacy
Laacy May. 8 at 1:36 PM
$SLS $IBRX $SRPT $IOVA $CING I have the worst port in the market I swear to gosh
1 Ā· Reply
Laacy
Laacy May. 8 at 1:32 PM
$CING drops every freaking day at open
0 Ā· Reply
alfi79
alfi79 May. 8 at 12:26 PM
1 Ā· Reply
Torben96
Torben96 May. 8 at 6:32 AM
$CING I am ready for patent news
0 Ā· Reply
Latest News on CING
Six new option listings on April 22nd

2026-04-22T13:47:28.000Z - 16 days ago

Six new option listings on April 22nd

NUCL VGNT XNDU


Cingulate announces U.S. patent notice of allowance

2026-03-18T12:12:11.000Z - 7 weeks ago

Cingulate announces U.S. patent notice of allowance


Cingulate reports Q4 net loss $6.3M vs. $6.2M last year

2026-03-18T12:05:55.000Z - 7 weeks ago

Cingulate reports Q4 net loss $6.3M vs. $6.2M last year


Cingulate sees cash runway into late 4Q26

2026-03-18T12:05:40.000Z - 7 weeks ago

Cingulate sees cash runway into late 4Q26


Why did Cingulate stock skyrocket today?

Mar 16, 2026, 1:26 PM EDT - 7 weeks ago

Why did Cingulate stock skyrocket today?


Cingulate files $200M mixed securities shelf

2026-01-12T22:15:20.000Z - 4 months ago

Cingulate files $200M mixed securities shelf


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T12:40:10.000Z - 6 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T00:55:07.000Z - 6 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year

2025-11-13T13:16:41.000Z - 6 months ago

Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year


Cingulate names Downey as CCO to lead launch prep for CTx-1301

2025-11-10T13:25:38.000Z - 6 months ago

Cingulate names Downey as CCO to lead launch prep for CTx-1301


Cingulate price target raised to $17 from $10 at Roth Capital

2025-10-15T01:25:08.000Z - 7 months ago

Cingulate price target raised to $17 from $10 at Roth Capital


Cingulate price target lowered to $10 from $11 at Roth Capital

2025-08-20T21:40:18.000Z - 9 months ago

Cingulate price target lowered to $10 from $11 at Roth Capital


Cingulate reports Q2 net loss ($4.8M) vs ($3.2M) last year

2025-08-19T12:50:08.000Z - 9 months ago

Cingulate reports Q2 net loss ($4.8M) vs ($3.2M) last year


Cingulate places CEO Schaffer on administrative leave

2025-08-15T13:10:52.000Z - 9 months ago

Cingulate places CEO Schaffer on administrative leave


Cingulate Provides Management Team Update

Aug 15, 2025, 9:00 AM EDT - 9 months ago

Cingulate Provides Management Team Update


Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 1 year ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 1 year ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 1 year ago

Cingulate Announces Adjournment of Special Meeting


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 2 years ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 2 years ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 2 years ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

Jan 29, 2024, 8:00 AM EST - 2 years ago

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO


Cingulate to Host CNS Key Opinion Leader Panel in New York City

Oct 17, 2023, 2:22 PM EDT - 2 years ago

Cingulate to Host CNS Key Opinion Leader Panel in New York City


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 2 years ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 2 years ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


Cingulate Announces Closing of $4.0 Million Public Offering

Sep 13, 2023, 4:15 PM EDT - 2 years ago

Cingulate Announces Closing of $4.0 Million Public Offering


Cingulate Announces Pricing of $4.0 Million Public Offering

Sep 11, 2023, 9:22 AM EDT - 2 years ago

Cingulate Announces Pricing of $4.0 Million Public Offering


StockJock73
StockJock73 May. 8 at 10:18 PM
$CING Just wake me up on May 32nd with an FDA approval please !!! šŸ€šŸ€šŸ€šŸ‚šŸ‚šŸ‚
0 Ā· Reply
alfi79
alfi79 May. 8 at 9:24 PM
$CING big buys today guys from VanguardšŸ˜±šŸ’Ŗ smart money is already starting to position itself!!!
1 Ā· Reply
PaulWalter
PaulWalter May. 8 at 8:25 PM
$CING Well, they haven’t buried bad news late on a Friday. Very cautiously optimistic.
0 Ā· Reply
Merlintrader
Merlintrader May. 8 at 7:50 PM
$CING Cingulate ( $CING ) vs Aytu BioPharma ( $AYTU ): What a Commercial ADHD Peer Can — and Cannot — Tell Us Before CING’s May 31 PDUFA https://www.merlintrader.com/cingulate-vs-aytu-biopharma-may2026-comparison/
0 Ā· Reply
biotechMDshortcut
biotechMDshortcut May. 8 at 3:58 PM
$CING full steam ahead. 24k in this boy for pdufa. 20% stop loss.
1 Ā· Reply
hossam94
hossam94 May. 8 at 2:02 PM
$CING someone know anything herešŸ˜‘?!
1 Ā· Reply
Laacy
Laacy May. 8 at 1:36 PM
$SLS $IBRX $SRPT $IOVA $CING I have the worst port in the market I swear to gosh
1 Ā· Reply
Laacy
Laacy May. 8 at 1:32 PM
$CING drops every freaking day at open
0 Ā· Reply
alfi79
alfi79 May. 8 at 12:26 PM
1 Ā· Reply
Torben96
Torben96 May. 8 at 6:32 AM
$CING I am ready for patent news
0 Ā· Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX May. 8 at 1:34 AM
$CING Little poll from the Discord today
1 Ā· Reply
President_Dwayne_Camacho
President_Dwayne_Camacho May. 8 at 12:48 AM
$CING Building a position for PDUFA
0 Ā· Reply
FCZ04
FCZ04 May. 8 at 12:17 AM
3 Ā· Reply
sam9420
sam9420 May. 7 at 4:52 PM
$CING we need to be happy here ,I wish great news coming soon
1 Ā· Reply
activehybrid
activehybrid May. 7 at 2:16 PM
$CING someone bought 40,000 shares at $5.31 Dude , what’s going on !
1 Ā· Reply
activehybrid
activehybrid May. 7 at 1:56 PM
$CING something I never seen on level 2 data Someone bought 26,700 shares at $5.30
1 Ā· Reply
alfi79
alfi79 May. 7 at 1:51 PM
$CING šŸ’Ŗ
0 Ā· Reply
hossam94
hossam94 May. 7 at 1:44 PM
$CING someone know something bought 19k shares at 5.35 $ at this time
1 Ā· Reply
Nattees
Nattees May. 7 at 11:03 AM
$CING valid
0 Ā· Reply
stockchacing
stockchacing May. 7 at 9:40 AM
$CING Not selling a CINGle share before Q1 2027, if at all... this is a longterm hold and shares could be worth mid to high 3digits number. Very
4 Ā· Reply
Kgra
Kgra May. 7 at 1:15 AM
$CING I looked at 4 different companies that had 90 day extensions to pdufa . Unfortunately no consistency, 2 were notified about 6 weeks before pdufa and 2 of them about 2 days before pdufa . All of them were considered major amendments to the filing . Which was not the case for cing . šŸ‘So basically it’s going to come down to the big day itself . I’m still leaning on the approval side. No efficacy issues , mfg issues basically as we understood which bio bend is not knew to this game . They prob pulled the A team out and knew from experience and exactly how quickly they needed to respond to fda issues , I think it’s mar 16 when they got the 483 which should have been enough time to respond and still leave fda time to overview again imo
2 Ā· Reply
ibaian
ibaian May. 6 at 11:58 PM
$CING it can touch $ 40 on approval, hope for the best
0 Ā· Reply